Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Hart

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Cardiovascular Clinics|January 1, 1981
Therapeutic considerations in the treatment of common cardiac arrhythmiasN J Hart
Cytotherapy|June 19, 2004
Loading DCs with AgF Vari, D N J Hart
Current Opinion in Molecular Therapeutics|March 12, 2002
Current issues in dendritic cell cancer immunotherapyJosé Alejandro López, Derek N J Hart
Current Drug Targets|January 24, 2004
Dendritic cells in tumor immunology and immunotherapyC J Turtle, D N J Hart
Blood|September 28, 2002
Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytesYuko Osugi, Slavica Vuckovic, Derek N J Hart
Methods in Molecular Biology (Clifton, N.J.)|November 27, 2009
Review of human DC subtypesXinsheng Ju, Georgina Clark, Derek N J Hart
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2007
Dendritic cells in transplantation and immune-based therapiesJames W Young, Miriam Merad, Derek N J Hart
Pathology|December 24, 2005
Vaccine strategies to treat lymphoproliferative disordersKristen J Radford, Frank Vari, Derek N J Hart
Current Pharmaceutical Design|June 19, 2002
Growth factors, cytokines and dendritic cell developmentS Vuckovic, G J Clark, D N J Hart
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
CMRF-56 immunoselected blood dendritic cell preparations activated with GM-CSF induce potent antimyeloma cytotoxic T-cell responsesJennifer L Freeman, Frank Vari, Derek N J Hart
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Cardiovascular Clinics|January 1, 1981
Therapeutic considerations in the treatment of common cardiac arrhythmiasN J Hart
Cytotherapy|June 19, 2004
Loading DCs with AgF Vari, D N J Hart
Current Opinion in Molecular Therapeutics|March 12, 2002
Current issues in dendritic cell cancer immunotherapyJosé Alejandro López, Derek N J Hart
Current Drug Targets|January 24, 2004
Dendritic cells in tumor immunology and immunotherapyC J Turtle, D N J Hart
Blood|September 28, 2002
Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytesYuko Osugi, Slavica Vuckovic, Derek N J Hart
Methods in Molecular Biology (Clifton, N.J.)|November 27, 2009
Review of human DC subtypesXinsheng Ju, Georgina Clark, Derek N J Hart
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2007
Dendritic cells in transplantation and immune-based therapiesJames W Young, Miriam Merad, Derek N J Hart
Pathology|December 24, 2005
Vaccine strategies to treat lymphoproliferative disordersKristen J Radford, Frank Vari, Derek N J Hart
Current Pharmaceutical Design|June 19, 2002
Growth factors, cytokines and dendritic cell developmentS Vuckovic, G J Clark, D N J Hart
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
CMRF-56 immunoselected blood dendritic cell preparations activated with GM-CSF induce potent antimyeloma cytotoxic T-cell responsesJennifer L Freeman, Frank Vari, Derek N J Hart
Pageof 9